Drugs / tPA
last change Dec 2015 re-read 3 minutes ago

tPA

Developed for
stroke disorder
Investigated by
Genentech, Inc. · Johns Hopkins University

Trials 1

201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01643902 Jan 2013 → Dec 2015 stroke disorder Johns Hopkins University Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as tPA ClinicalTrials.gov intervention name — accepted as the source's own label NCT01643902 ↗
Route Intravenous “by intravenous bolus injection” NCT01643902 ↗